ARCHIVES

FDA Expands Gleevec Indication For Children with Ph+ ALL

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995

In Brief: NCCS Honors 14 Who Make A Difference; Lasker Awards Presented To Seven Scientists

October 2, 1998

FDA Grants Accelerated Approval To Mekinist-Tafinlar Combination

January 31, 2014

Genentech’s Ferrara Selected for GM Award.

June 23, 2006

Clinical Trials Approved By NCI Last Month Are Listed

April 25, 2003

Study Links Exercise and Survival In Breast and Colon Cancer Mortality

May 25, 2012